KRS
NKTR icon

Kentucky Retirement Systems’s Nektar Therapeutics NKTR Stock Holding History

Kentucky Retirement Systems’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-541
Closed -$289K – 498
2019
Q2 		$289K Buy
541
+34
+7% +$17K 0.03% 474
2019
Q1 		$256K Buy
507
+5
+1% +$2.96K 0.02% 483
2018
Q4 		$247K Buy
502
+12
+2% +$7.24K 0.03% 471
2018
Q3 		$448K Buy
490
+34
+7% +$29K 0.04% 419
2018
Q2 		$334K Sell
456
-104
-19% -$120K 0.03% 461
2018
Q1 		$892K Buy
+560
New +$721K 0.08% 280

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kentucky Retirement Systems's NKTR Position: Q3 2019 in Review

Kentucky Retirement Systems sold out of Nektar Therapeutics (NKTR) in Q3 2019, closing a stake of 541 shares — an estimated $289K sold.

Kentucky Retirement Systems first reported a position in NKTR in Q1 2018 and held it in 6 quarters. The position peaked at $892K in Q1 2018. 287 funds tracked by Wall St. Rank hold NKTR as of Q3 2019.

  • Kentucky Retirement Systems reported no remaining Nektar Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Kentucky Retirement Systems sold 541 Nektar Therapeutics shares in Q3 2019, an estimated $289K.
  • Kentucky Retirement Systems first reported a position in Nektar Therapeutics in Q1 2018 and held it in 6 quarters.
  • Kentucky Retirement Systems's Nektar Therapeutics position peaked at $892K in Q1 2018.
  • 287 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2019.

Based on Kentucky Retirement Systems's 13F filing for Q3 2019, filed 5 Nov 2019.